Early Infantile Epileptic Encephalopathy 4 (EIEE4)

1. Causes of the disease

Early infantile epileptic encephalopathy type 4 (EIEE4) is a severe epileptic encephalopathy caused by mutations in the ARX gene, which is involved in nervous system development, and mutations in the gene disrupt the normal functioning of neurons, resulting in epileptic seizures.

2. Symptoms

• Severe epileptic seizures : Seizures may occur within the first few months of life and may involve convulsions and reduced responsiveness.
• Developmental delays : Significant delays in motor, language, and intellectual development.
• Muscle weakness : Abnormal muscle tone and muscle weakness may be observed.
• Behavioral abnormalities : Some patients may exhibit hyperactivity or autism spectrum behaviors.

3. Treatment

• Seizure management : Antiepileptic drugs and other seizure treatments are used as needed.
• Developmental Support : Support is provided to promote development through physical, occupational and speech therapy.
• Behavioral support : Help for behavioral issues may also be provided.

4. Prognosis

Epilepsy is often difficult to control and the prognosis can be grim, but with early diagnosis and appropriate treatment, symptoms can be alleviated.

5. The burden on parents

Long-term management of severe epilepsy and developmental delays is necessary, which places a heavy burden on parents. It is important to receive support by utilizing medical and welfare services.